StockData
Biotricity Inc. logo

Biotricity Inc. (BTCY) stock

BTCYOTCSurgical & Medical Instruments & ApparatusFiscal year ends March 31
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 19, 2026Score 4/30
$0.05+0.00 (+8.70%)

Close on Oct 19, 2026Market cap $1.15MP/E –Yield –

Biotricity operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Biotricity's operating income for the twelve months ending Jun 30, 2026 was $1.57M. For fiscal 2026 it was $1.69M. The highest annual figure on record is $1.69M in fiscal 2026.

Annual operating income

PeriodPeriod endValueChange
FY2026Mar 31, 2026$1.69M–
FY2025Mar 31, 2025-$2.45M–
FY2024Mar 31, 2024-$8.83M–
FY2023Mar 31, 2023-$15.41M–
FY2022Mar 31, 2022-$16.74M–

Quarterly operating income

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q1 FY2027CQ2 2026Jun 30, 2026$158.07K-43.9%
Q4 FY2026CQ1 2026Mar 31, 2026$694.56K–
Q3 FY2026CQ4 2025Dec 31, 2025$440.92K–
Q2 FY2026CQ3 2025Sep 30, 2025$273.82K–
Q1 FY2026CQ2 2025Jun 30, 2025$281.95K–
Q4 FY2025CQ1 2025Mar 31, 2025-$855.47K–
Q3 FY2025CQ4 2024Dec 31, 2024-$168.98K–
Q2 FY2025CQ3 2024Sep 30, 2024-$307.67K–
Q1 FY2025CQ2 2024Jun 30, 2024-$1.12M–
Q4 FY2024CQ1 2024Mar 31, 2024-$3.04M–
Q3 FY2024CQ4 2023Dec 31, 2023-$1.28M–
Q2 FY2024CQ3 2023Sep 30, 2023-$2.19M–
Q1 FY2024CQ2 2023Jun 30, 2023-$2.32M–
Q4 FY2023CQ1 2023Mar 31, 2023-$3.45M–
Q3 FY2023CQ4 2022Dec 31, 2022-$3.84M–
Q4 FY2022CQ1 2022Mar 31, 2022-$3.83M–
Q3 FY2022CQ4 2021Dec 31, 2021-$4.74M–

More Biotricity figures

See a number that looks wrong?